(Q44321000)

1 December 2017

title

Attenuation of proteolysis and muscle wasting by curcumin c3 complex in MAC16 colon tumour-bearing mice (English)

1 reference

1 December 2017

0 references

1 reference

Rafat A Siddiqui

1

1 reference

1 December 2017

Samira Hassan

2

1 reference

1 December 2017

Kevin A Harvey

3

1 reference

1 December 2017

Tamkeen Rasool

4

1 reference

1 December 2017

Tapas Das

5

1 reference

1 December 2017

Pradip Mukerji

6

1 reference

1 December 2017

Stephen DeMichele

7

1 reference

1 December 2017

publication date

27 April 2009

1 reference

British Journal of Nutrition

1 December 2017

published in

1 reference

1 December 2017

volume

102

1 reference

1 December 2017

issue

7

1 reference

1 December 2017

page(s)

967-975

1 reference

Nutrition modulation of cachexia/proteolysis

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

Constitutive activation of MAPK cascade in acute quadriplegic myopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

Induction of MafBx and Murf ubiquitin ligase mRNAs in rat skeletal muscle after LPS injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

Role of the ubiquitin-proteasome pathway in sepsis-induced muscle catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

Identification of ubiquitin ligases required for skeletal muscle atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

The ubiquitin-proteasome proteolysis pathway: potential target for disease intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

What do we really know about the ubiquitin-proteasome pathway in muscle atrophy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

IKKbeta/NF-kappaB activation causes severe muscle wasting in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

What we have learned about cachexia in gastrointestinal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

Attenuation of proteasome-induced proteolysis in skeletal muscle by {beta}-hydroxy-{beta}-methylbutyrate in cancer-induced muscle loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

Incidence of weight loss in head and neck cancer patients on commencing radiotherapy treatment at a regional oncology centre

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

Increased expression of the ubiquitin-proteasome pathway in murine myotubes by proteolysis-inducing factor (PIF) is associated with activation of the transcription factor NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

Dose escalation of a curcuminoid formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

The origins of cachexia in acute and chronic inflammatory diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

Curcumin, a natural product present in turmeric, decreases tumor growth but does not behave as an anticachectic compound in a rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

The syndrome of cardiac cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

Curcumin prevents lipopolysaccharide-induced atrogin-1/MAFbx upregulation and muscle mass loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

Sublethal Hemorrhage Induces Tolerance in Animals Exposed to Cecal Ligation and Puncture by Altering p38, p44/42, and SAPK/JNK MAP Kinase Activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

Nutrition and cardiac cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

Inhibition of proteasomal function by curcumin induces apoptosis through mitochondrial pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

Role of curcumin in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

The NF-kappaB inhibitor curcumin blocks sepsis-induced muscle proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

Curcumin as "Curecumin": from kitchen to clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

TNF-alpha increases ubiquitin-conjugating activity in skeletal muscle by up-regulating UbcH2/E220k

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

Biological properties of curcumin-cellular and molecular mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

The curcuma antioxidants: pharmacological effects and prospects for future clinical use. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

Pharmacology of Curcuma longa

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

Cancer anorexia-cachexia syndrome: current issues in research and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

Effect of home total parenteral nutrition on body composition in patients with acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

7 January 2021

Ubiquitin Gene Expression in Skeletal Muscle Is Increased by Tumor Necrosis Factor-α

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

7 January 2021

Different cytokines modulate ubiquitin gene expression in rat skeletal muscle

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

7 January 2021

Systemic administration of the NF-kappaB inhibitor curcumin stimulates muscle regeneration after traumatic injury.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

7 January 2021

Dietary intake, resting energy expenditure, weight loss and survival in cancer patients

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

7 January 2021

Thwarting the dwindling progression of cachexia

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

7 January 2021

Disuse atrophy and exercise rehabilitation in humans profoundly affects the expression of genes associated with the regulation of skeletal muscle mass.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

7 January 2021

NF-kappaB mediates the protein loss induced by TNF-alpha in differentiated skeletal muscle myotubes

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

7 January 2021

TNF Can Directly Induce the Expression of Ubiquitin-Dependent Proteolytic System in Rat Soleus Muscles

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

7 January 2021

https://api.crossref.org/works/10.1017%2FS0007114509345250

1 reference

7 January 2021

Cachexia: time to receive more attention

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

7 January 2021

Proteasome proteolytic activity in skeletal muscle is increased in patients with sepsis

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

7 January 2021

[Value of megestrol acetate in treatment of cachexia in head-neck tumors]

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

7 January 2021

Sepsis upregulates the gene expression of multiple ubiquitin ligases in skeletal muscle

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

7 January 2021

Induction of proteasome expression in skeletal muscle is attenuated by inhibitors of NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

7 January 2021

Muscle wasting associated with cancer cachexia is linked to an important activation of the atp-dependent ubiquitin-mediated proteolysis

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

7 January 2021

Muscle protein breakdown and the critical role of the ubiquitin-proteasome pathway in normal and disease states

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

7 January 2021

Progressive nuclear factor-kappaB activation resistant to inhibition by contraction and curcumin in mdx mice

1 reference

https://api.crossref.org/works/10.1017%2FS0007114509345250

7 January 2021

10.1017/S0007114509345250

Identifiers

DOI

1 reference

1 December 2017

1 reference